|
|
No evidence of hepatitis B virus reactivation among liver transplant recipients treated with interferon- free regimens for hepatitis C virus recurrence (ANRS CO23 CUPILT Cohort)
Lina Mouna
,
Emilie Rossignol
,
Mariagrazia Tateo
,
Jean-Charles Duclos-Vallee
,
Christophe Duvoux
et al.
Hepatology, 2017, 66, pp.873A-874A
Journal articles
hal-01769634v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence Prophylaxis makes the difference
Lina Mouna
,
Emilie Rossignol
,
Mariagrazia Tateo
,
Audrey Coilly
,
Jean-Charles Duclos-Vallee
et al.
Journal articles
hal-02120675v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Drivers of outcome in compensated alcohol-related cirrhosis: a prospective study
Alexandre Louvet
,
Cendrine Chaffaut
,
Jerome Gournay
,
Frederic Oberti
,
Laure Elkrief
et al.
Journal of Hepatology, 2021, 75 (2), pp.S312
Journal articles
hal-03946473v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Achieving SVR Does Not Prevent From Fibrosis Progession In Patients With FCH Results From A Large French Prospective Multicentric ANRS CO23 Cupilt Cohort
Mylene Sebagh
,
Claire Fougerou-Leurent
,
Georges-Philippe Pageaux
,
Vincent Leroy
,
Jerome Dumortier
et al.
Hepatology, 2017, 66, pp.872A-872A
Journal articles
hal-01769633v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
PERSISTENT MODERATE ALCOHOL CONSUMPTION IMPACTS SURVIVAL IN PATIENTS WITH COMPENSATED ALCOHOL-RELATED CIRRHOSIS: ANALYSIS OF THE CIRRAL COHORT.
Alexandre Louvet
,
Cendrine Chaffaut
,
Isabelle Archambeaud Mabile
,
Frederic Oberti
,
Louis D. Alteroche
et al.
Hepatology, 2021, 74 (1), pp.87A-88A
Journal articles
hal-03590851v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Predictive Factors for Hepatocellular Carcinoma in Chronic Hepatitis B Using Structural Equation Modeling: A Prospective Cohort Study
Laurent Lam
,
Hélène Fontaine
,
Marc Bourliere
,
Clovis Lusivika-Nzinga
,
Céline Dorival
et al.
Journal articles
hal-03224103v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?
Audrey Coilly
,
Jérôme Dumortier
,
Danielle Botta-Fridlund
,
Marianne Latournerie
,
Vincent Leroy
et al.
Journal articles
hal-01326372v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation
Pauline Houssel-Debry
,
Audrey Coilly
,
Claire Fougerou-Leurent
,
Caroline Jezequel
,
Christophe Duvoux
et al.
Journal articles
hal-01807755v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|